iifl-logo

Parenteral Drugs India Ltd Cash Flow Statement

2.9
(1.75%)
Aug 21, 2023|01:45:11 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Parenteral Drugs FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

-154.47

-141.73

-119.4

-125.06

Depreciation

-17.32

-17.34

-18.56

-19.1

Tax paid

32.75

27.66

23.31

11.07

Working capital

-137.33

-242.01

-101.49

-144.23

Other operating items

Operating

-276.36

-373.42

-216.14

-277.31

Capital expenditure

0

-0.97

2.32

0

Free cash flow

-276.36

-374.39

-213.82

-277.31

Equity raised

-1,182.75

-614.97

-6.26

306.14

Investing

0

0

-0.47

-135.64

Financing

59.04

61.16

140.58

226.03

Dividends paid

0

0

0

0

Net in cash

-1,400.08

-928.19

-79.98

119.21

Parenteral Drugs : related Articles

No Record Found

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.